ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Boehringer Ingelheim will acquire Amgen’s biologic manufacturing facility in Fremont, Calif., and make the plant part of its contract manufacturing network. Amgen obtained the plant, which employs about 260 people, through its 2006 purchase of Abgenix. Boehringer says it will continue to serve Amgen, for which it has been a contract manufacturer for more than 10 years. Separately, Boehringer has agreed to sell its Resomer pharmaceutical polymers business to Evonik Industries. Based on lactic and glycolic acids, Resomer polymers are fully biodegradable in the body, Evonik says.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X